中文 | English
Return
Total: 44 , 1/5
Show Home Prev Next End page: GO
Author:(Shuo HOU)

1.Cost-effectiveness analysis of cefiderocol for the treatment of confirmed or suspected carbapenem-resistant Gram-negative bacteria serious infections

Yuan GONG ; Shuo KANG ; Yibing HOU ; Xiaohui WANG ; Ying NIE ; Jing WANG ; Zhenhua PAN

China Pharmacy 2026;37(2):192-197

2.Prognostic Factors of Liposarcoma in Head and Neck

Shuo DING ; Zhigang HUANG ; Jugao FANG ; Yang ZHANG ; Lizhen HOU ; Wei GUO ; Gaofei YIN ; Qi ZHONG

Cancer Research on Prevention and Treatment 2025;52(1):31-35

3.Rapid health technology assessment of serplulimab in the first-line treatment of small-cell lung cancer

Yibing HOU ; Shuo KANG ; Yuan GONG ; Xiaohui WANG ; Ying NIE ; Huanlong LIU

China Pharmacy 2025;36(11):1405-1410

4.Exploration of the nervous organ-system-based curriculum

Shuai HOU ; Shuo HUANG

Journal of Apoplexy and Nervous Diseases 2025;42(1):94-96

5.Correlation between differences in starch gelatinization, water distribution, and terpenoid content during steaming process of Curcuma kwangsiensis root tubers by multivariate statistical analysis.

Yan LIANG ; Meng-Na YANG ; Xiao-Li QIN ; Zhi-Yong ZHANG ; Zhong-Nan SU ; Hou-Kang CAO ; Ke-Feng ZHANG ; Ming-Wei WANG ; Bo LI ; Shuo LI

China Journal of Chinese Materia Medica 2025;50(10):2684-2694

6.A joint distillation model for the tumor segmentation using breast ultrasound images.

Hongjiang GUO ; Youyou DING ; Hao DANG ; Tongtong LIU ; Xuekun SONG ; Ge ZHANG ; Shuo YAO ; Daisen HOU ; Zongwang LYU

Journal of Biomedical Engineering 2025;42(1):148-155

8.Sinicization and psychometric validation of the German Pelvic Floor Questionnaire for Pregnant and Postpartum Women.

Liping ZHU ; Chengyu ZHOU ; Xuhong LI ; Qiao HOU ; Shuo YANG

Journal of Central South University(Medical Sciences) 2025;50(1):72-80

9.Establishment and evaluation of a machine learning prediction model for sepsis-related encephalopathy in the elderly.

Xiao YUE ; Yiwen WANG ; Zhifang LI ; Lei WANG ; Li HUANG ; Shuo WANG ; Yiming HOU ; Shu ZHANG ; Zhengbin WANG

Chinese Critical Care Medicine 2025;37(10):937-943

10.Cost-utility analysis of capivasertib combined with fulvestrant in the second-line treatment of HR+/HER2- advanced breast cancer

Yang ZHANG ; Shuo KANG ; Xiaohui WANG ; Yibing HOU ; Xiangxia FU ; Huanlong LIU

China Pharmacy 2025;36(24):3073-3078

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 44 , 1/5 Show Home Prev Next End page: GO